Global Neuromyelitis Optica Drug Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Neuromyelitis Optica Drug

• 1.1 Definition of Neuromyelitis Optica Drug
• 1.2 Neuromyelitis Optica Drug Segment by Type
  • 1.2.1 Global Neuromyelitis Optica Drug Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Glucocorticoids
  • 1.2.3 Immunoglobulin
  • 1.2.4 Other
• 1.3 Neuromyelitis Optica Drug Segment by Applications
  • 1.3.1 Global Neuromyelitis Optica Drug Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Acute attack
  • 1.3.3 Remission prophylactic treatment
• 1.4 Global Neuromyelitis Optica Drug Overall Market
  • 1.4.1 Global Neuromyelitis Optica Drug Revenue (2014-2025)
  • 1.4.2 Global Neuromyelitis Optica Drug Production (2014-2025)
  • 1.4.3 North America Neuromyelitis Optica Drug Status and Prospect (2014-2025)
  • 1.4.4 Europe Neuromyelitis Optica Drug Status and Prospect (2014-2025)
  • 1.4.5 China Neuromyelitis Optica Drug Status and Prospect (2014-2025)
  • 1.4.6 Japan Neuromyelitis Optica Drug Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Neuromyelitis Optica Drug Status and Prospect (2014-2025)
  • 1.4.8 India Neuromyelitis Optica Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Neuromyelitis Optica Drug
• 2.3 Manufacturing Process Analysis of Neuromyelitis Optica Drug
• 2.4 Industry Chain Structure of Neuromyelitis Optica Drug

3 Development and Manufacturing Plants Analysis of Neuromyelitis Optica Drug

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Neuromyelitis Optica Drug Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Neuromyelitis Optica Drug
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Neuromyelitis Optica Drug Production and Capacity Analysis
• 4.2 Neuromyelitis Optica Drug Revenue Analysis
• 4.3 Neuromyelitis Optica Drug Price Analysis
• 4.4 Market Concentration Degree

5 Neuromyelitis Optica Drug Regional Market Analysis

• 5.1 Neuromyelitis Optica Drug Production by Regions
  • 5.1.1 Global Neuromyelitis Optica Drug Production by Regions
  • 5.1.2 Global Neuromyelitis Optica Drug Revenue by Regions
• 5.2 Neuromyelitis Optica Drug Consumption by Regions
• 5.3 North America Neuromyelitis Optica Drug Market Analysis
  • 5.3.1 North America Neuromyelitis Optica Drug Production
  • 5.3.2 North America Neuromyelitis Optica Drug Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Neuromyelitis Optica Drug Import and Export
• 5.4 Europe Neuromyelitis Optica Drug Market Analysis
  • 5.4.1 Europe Neuromyelitis Optica Drug Production
  • 5.4.2 Europe Neuromyelitis Optica Drug Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Neuromyelitis Optica Drug Import and Export
• 5.5 China Neuromyelitis Optica Drug Market Analysis
  • 5.5.1 China Neuromyelitis Optica Drug Production
  • 5.5.2 China Neuromyelitis Optica Drug Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Neuromyelitis Optica Drug Import and Export
• 5.6 Japan Neuromyelitis Optica Drug Market Analysis
  • 5.6.1 Japan Neuromyelitis Optica Drug Production
  • 5.6.2 Japan Neuromyelitis Optica Drug Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Neuromyelitis Optica Drug Import and Export
• 5.7 Southeast Asia Neuromyelitis Optica Drug Market Analysis
  • 5.7.1 Southeast Asia Neuromyelitis Optica Drug Production
  • 5.7.2 Southeast Asia Neuromyelitis Optica Drug Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Neuromyelitis Optica Drug Import and Export
• 5.8 India Neuromyelitis Optica Drug Market Analysis
  • 5.8.1 India Neuromyelitis Optica Drug Production
  • 5.8.2 India Neuromyelitis Optica Drug Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Neuromyelitis Optica Drug Import and Export

6 Neuromyelitis Optica Drug Segment Market Analysis (by Type)

• 6.1 Global Neuromyelitis Optica Drug Production by Type
• 6.2 Global Neuromyelitis Optica Drug Revenue by Type
• 6.3 Neuromyelitis Optica Drug Price by Type

7 Neuromyelitis Optica Drug Segment Market Analysis (by Application)

• 7.1 Global Neuromyelitis Optica Drug Consumption by Application
• 7.2 Global Neuromyelitis Optica Drug Consumption Market Share by Application (2014-2019)

8 Neuromyelitis Optica Drug Major Manufacturers Analysis

• 8.1 Pfizer
  • 8.1.1 Pfizer Neuromyelitis Optica Drug Production Sites and Area Served
  • 8.1.2 Pfizer Product Introduction, Application and Specification
  • 8.1.3 Pfizer Neuromyelitis Optica Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Fresenius
  • 8.2.1 Fresenius Neuromyelitis Optica Drug Production Sites and Area Served
  • 8.2.2 Fresenius Product Introduction, Application and Specification
  • 8.2.3 Fresenius Neuromyelitis Optica Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 TEVA
  • 8.3.1 TEVA Neuromyelitis Optica Drug Production Sites and Area Served
  • 8.3.2 TEVA Product Introduction, Application and Specification
  • 8.3.3 TEVA Neuromyelitis Optica Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Sandoz
  • 8.4.1 Sandoz Neuromyelitis Optica Drug Production Sites and Area Served
  • 8.4.2 Sandoz Product Introduction, Application and Specification
  • 8.4.3 Sandoz Neuromyelitis Optica Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Intas
  • 8.5.1 Intas Neuromyelitis Optica Drug Production Sites and Area Served
  • 8.5.2 Intas Product Introduction, Application and Specification
  • 8.5.3 Intas Neuromyelitis Optica Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Gyjtrs
  • 8.6.1 Gyjtrs Neuromyelitis Optica Drug Production Sites and Area Served
  • 8.6.2 Gyjtrs Product Introduction, Application and Specification
  • 8.6.3 Gyjtrs Neuromyelitis Optica Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Nang Kuang
  • 8.7.1 Nang Kuang Neuromyelitis Optica Drug Production Sites and Area Served
  • 8.7.2 Nang Kuang Product Introduction, Application and Specification
  • 8.7.3 Nang Kuang Neuromyelitis Optica Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Tianjin Kingyork
  • 8.8.1 Tianjin Kingyork Neuromyelitis Optica Drug Production Sites and Area Served
  • 8.8.2 Tianjin Kingyork Product Introduction, Application and Specification
  • 8.8.3 Tianjin Kingyork Neuromyelitis Optica Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Baxter
  • 8.9.1 Baxter Neuromyelitis Optica Drug Production Sites and Area Served
  • 8.9.2 Baxter Product Introduction, Application and Specification
  • 8.9.3 Baxter Neuromyelitis Optica Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 CSL
  • 8.10.1 CSL Neuromyelitis Optica Drug Production Sites and Area Served
  • 8.10.2 CSL Product Introduction, Application and Specification
  • 8.10.3 CSL Neuromyelitis Optica Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Grifols
• 8.12 Octapharma
• 8.13 CBOP

9 Development Trend of Analysis of Neuromyelitis Optica Drug Market

• 9.1 Global Neuromyelitis Optica Drug Market Trend Analysis
  • 9.1.1 Global Neuromyelitis Optica Drug Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Neuromyelitis Optica Drug Regional Market Trend
  • 9.2.1 North America Neuromyelitis Optica Drug Forecast 2019-2025
  • 9.2.2 Europe Neuromyelitis Optica Drug Forecast 2019-2025
  • 9.2.3 China Neuromyelitis Optica Drug Forecast 2019-2025
  • 9.2.4 Japan Neuromyelitis Optica Drug Forecast 2019-2025
  • 9.2.5 Southeast Asia Neuromyelitis Optica Drug Forecast 2019-2025
  • 9.2.6 India Neuromyelitis Optica Drug Forecast 2019-2025
• 9.3 Neuromyelitis Optica Drug Market Trend (Product Type)
• 9.4 Neuromyelitis Optica Drug Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Neuromyelitis Optica Drug Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List